The PCA1 cluster exhibited higher CRPC-AR module score compared to PCA2 and PCA3 clusters (Fig. 1e), suggesting its classification as an AR-positive prostate cancer (ARPC) subtype. The gene discussed is CASC19; the disease is prostate carcinoma.